We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficul
Tchaikapharma High Quality Medicines Inc. remains the most expensive Bulgarian company on the Bulgarian Stock Exchange. After the market capitalization of the pharmaceutical company exceeded BGN 1 bil
Tchaikapharma High Quality Medicines retains its position as the most expensive Bulgarian company on the BSE. After the players on the stock exchange estimated the pharmaceutical company at BGN 1,027,
There is a company on the Bulgarian Stock Exchange with a value of over a billion leva, according to data in the bulletin of the stock exchange operator for the second quarter. This is Tchaikapharma H
Tchaikapharma High Quality Medicines’ shares increased by 1.8% at the end of the trading Monday, March 23, and the closing price reached BGN 11.60. Since the beginning of the year, the company h
In the past year, Tchaikapharma has consolidated its leading position through the successful development of numerous scientific projects, the basis of which is advanced research work on the developmen
Distant leader in the treatment of cardiovascular disease among all drug manufacturers present on the Bulgarian market with market share 10.57% in 2017 and 11.39% for the first half of 2018 (Source:
The Financial Supervision Commission (FSC) registered the shares issued by Tchaikapharma High Quality Medicines Inc. as a result of an increase of the company’s capital with a view to trading on
The current capital of the pharmaceutical company is BGN 64.3 million. Tchaikapharma High Quality Medicines Inc. announced that following the entry in the Commercial Register the capital of the compan
The voted dividend for 2016 is 7 700 000. The amount of the capital after the increase is BGN 64 300 000. On June 8, 2017, the Annual General Meeting of Shareholders (GMS) of Tchaikapharma High Quali
On the basis of art.27, par.1. it. 2 of the Ordinance No. 2 of the Financial Supervision Commission (FSC), we notify the following circumstances relating to Tchaikapharma High Quality Medicines Inc.,
The outgoing 2016 was a wonderful year of continued progress for Tchaikapharma. It was the first full year since Tchaikapharma was listed as a public company on the Bulgarian Stock Exchange (BSE) in S
The decline in the price of shares of Sopharma during the trading session of Wednesday from 3.24% yesterday and the minimum recovery of only 0.24% led to a new leader among the largest public companie
A total of 8 among the 40 companies included in calculating one of the main indicators of the Bulgarian Stock Exchange – BGBX40, rose more than 10%, and nine companies lose between 13 and 58% of
By decision of the General Meeting, the company’s capital will be increased by BGN 7 million, which will increase in proportion the number of shares that each shareholder has. On 23rd June 2016,
For the past year the company has reported improved results in its financial performance, introducing new products and entering new markets, as well as advancing in the field of its research and devel
Tchaikapharma High Quality Medicines Inc. invites all of the shareholders of the Company to the Annual General Meeting which will be held on 23 June 2016. You can find the full invitation wording here
At the end of the trading day (Thursday 7 April) Tchaikapharma’s shares rose most significantly – they increased by 1.21% and the closing price reached BGN 5.85. This represents another appreciation o
Tchaikapharma High Quality Medicines Inc. successfully launched the trading week. On Monday, the company ranked third in traded volume, having trading volume of nearly BGN 33.4 thousand. The transacti
The results of the third quarter of 2015 confirmed the optimistic forecasts for the financial results of Tchaikapharma High Quality Medicines Inc. Obviously the long-term strategy for innovative, high
With the decision of 25.05.2015, the Financial Supervision Commission confirmed the supplement to the prospectus for capital increase and the admission to trading of another 6.1 million shares of Tcha
Today is the second trading day of the shares of Tchaikapharma High Quality Medicines AD. The Bulgarian Stock Exchange transactions were concluded at higher levels compared to yesterday – BGN 4.
The stock trade with the shares of Tchaikapharma High Quality Medicines AD has started at the Bulgarian Stock Exchange at the price of BGN 4.26 per share. The market closed with a demand for BGN 4.27
At a meeting of the Board of Directors of the Bulgarian Stock Exchange – Sofia AD, the following decision was taken in Protocol 19 / 13.05.2015: In connection with the submitted application purs
Tchaikapharma High Quality Medicines AD has declared the admission to trading of its shares on the Bulgarian Stock Exchange, was confirmed by the operator. The ISIN code of the issue is BG1100008074.